labarai

Amincewa da Aehealth BfArM

Gwajin Antigen na Aehealth 2019-nCov ya sami izini na musamman daga Cibiyar Kula da Magunguna da Na'urorin Lafiya ta Jamus (BfArM) bisa ga §11 sakin layi na 1 na Dokar Na'urar Likita ta Jamus (MPG) na gwajin antigen don gano coronavirus.

Mance da falsafar "Kyakkyawan kula da lafiya ga bil'adama", Aehealth ta ci gaba da aiki don gamsar da buƙatun duniya na saurin gwaje-gwaje a cikin rigakafin cutar sankarau a duk duniya.Aehealth 2019-nCoV Antigen Test (colloidal zinariya) wanda aka yi tare da samfurin swab daga kogon hanci yana ba da sakamako a cikin mintuna 15, yana rage lokacin ganowa sosai, idan aka kwatanta da hanyar PCR.Gwajin na iya ba masu amfani babban sassauci tare da kyakkyawan sakamako mai kyau.

Ministan Lafiya na Jamus Jens Spahn ya ce amincewa da gwajin rigakafin COVID-19 na ba da damar yawan jama'a su yi gwaji.Farkon gano mutanen asymptomatic na iya karya sarkar kamuwa da cuta yadda ya kamata, tare da dakatar da yaduwar kamuwa da cuta.

Gwajin Antigen Rapid COVID-19 shine colloidal zinariya immunochromatography wanda aka yi niyya don gano ingantattun antigens na nucleocapsid daga COVID-19 a cikin swabs na hanci, swabs na makogwaro ko miya daga mutanen da ake zargi da COVID-19 ta hanyar masu ba da kiwon lafiya.

Novel coronaviruses na cikin nau'in β.COVID-19 cuta ce mai saurin kamuwa da numfashi.

Sakamako shine don gano COVID-19 nucleocapsid antigen.Ana iya gano antigen gabaɗaya a cikin samfuran numfashi na sama ko ƙananan samfuran numfashi yayin lokacin kamuwa da cuta.

Sakamakon tabbatacce yana nuna kasancewar antigens na hoto, amma haɗin gwiwar asibiti tare da tarihin haƙuri da sauran bayanan bincike ya zama dole don sanin matsayin kamuwa da cuta.

Sakamakon tabbatacce baya kawar da kamuwa da cutar kwayan cuta ko kamuwa da wasu ƙwayoyin cuta.Antigen da aka gano bazai zama tabbataccen dalilin cutar ba.

Sakamakon mummunan ba zai kawar da COVID-19 kamuwa da cuta kuma bai kamata a yi amfani da shi azaman tushen kawai don magani ko yanke shawara na kulawa da haƙuri ba, gami da yanke shawarar sarrafa kamuwa da cuta.

Ya kamata a yi la'akari da mummunan sakamakon a cikin mahallin bayyanar majiyyaci kwanan nan, tarihi da kasancewar alamun asibiti da alamun da suka yi daidai da COVID-19 kuma an tabbatar da su tare da gwajin motsi, idan ya cancanta don sarrafa haƙuri.

A matsayin kamfanin da ke riƙe da takaddun shaida na gwajin antigen na 2019-nCoV, Aehealth ya himmatu wajen ba da gudummawa ga yaƙin duniya na annoba.Gwaje-gwajen Aehealth da yawa na COVID-19 sun sami amincewar alamar CE kuma ƙasar mai shigo da kaya ta inganta su bisa ga ƙa'idodi da ƙa'idodi na gida.Aehealth yanzu tana samar da "PCR+ Antigen+ Neutralization Antibody" hadedde bayani wanda ya dace da yanayin aikace-aikacen daban-daban na gano cutar ta COVID-19 nan take.


Lokacin aikawa: Dec-12-2021
Tambaya